What is Novartis India Limited's (NOVARTIND.NS) StockRank?

MoatMap's StockRank for Novartis India Limited (NOVARTIND.NS) is 30/100, with a Sell signal. This is a composite score combining Quality (72), Value (19), and Momentum (30) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Novartis India Limited have an economic moat?

Novartis India Limited (NOVARTIND.NS) has a Quality factor score of 72/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Novartis India Limited a buy, hold, or sell?

MoatMap's current signal for Novartis India Limited (NOVARTIND.NS) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Novartis India Limited in?

Novartis India Limited (NOVARTIND.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

NOVARTIND.NS

SellFallen Favourite

Novartis India Limited · Healthcare · India · $475M · Avg Vol: $1M/d

StockRank

Get insider-trade alerts

P/E (TTM)

55.3x

ROE

11.4%

D/E

0.0x

Dividend %

—

COMPANY DESCRIPTION

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.

FINANCIAL SUMMARY (INR)

Year	2023	2024	2025	2026	CAGR	TTM
Revenue	3.7B	3.3B	3.6B	3.5B	-1.4%	3.7B
EPS (INR)	41.86	34.50	40.87	37.74	-3.4%	39.54
Shares	24.7M	24.7M	24.7M	24.7M	0.0%	24.7M
Debt	215.1M	69.7M	50.6M	32.1M	-47.0%	32.1M
Equity	7.8B	7.4B	7.8B	8.2B	1.8%	—
Op CF	448.0M	1.1B	745.7M	467.3M	1.4%	467.3M
Inv CF	-1.5B	331.3M	-33.1M	176.3M	—	—
Fin CF	-304.8M	-1.2B	-641.5M	-639.3M	—	—

Loading 1Y...

PRICE (1Y)+38.8%

SMA 50SMA 200

$22.99

RSI (14)

89.8

SCORE BREAKDOWN

Quality

ROIC

15.7%84.6

ROE

11.4%74.4

GP/Assets

16.7%37.1

Op. Margin

33.2%93.7

FCF/Assets

4.7%68.9

Piotroski

668.8

Int. Cover

50.0x89.2

D/E Ratio

0.00x90.0

Current Ratio

5.30x73.7

Value

P/E (TTM)

55.3x19.6

EV/EBITDA

37.5x16.5

P/FCF

97.3x14.6

P/B

6.6x20.5

P/S

14.6x20.1

Div Yield

—N/A

Momentum

52W High %

—N/A

RS 6M

—N/A

SMA 50/200

—N/A

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

17%52.1

FUNDAMENTALS

Market Cap

$475M

P/E (Forward)

—

Gross Margin

44.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NOVARTIND.NS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
NOVARTIND.NS	Novartis India Limited(you)	$475M	30	Sell
ORCHPHARMA.NS	Orchid Pharma Limited	$517M	45	Hold
SHUKRAPHAR.NS	Shukra Pharmaceuticals Limited	$252M	38	Hold
SUVEN.NS	Suven Life Sciences Limited	$1.1B	34	Sell
GUJTHEM.NS	Gujarat Themis Biosyn Limited	$622M	52	Hold
ASTRAZEN.NS	AstraZeneca Pharma India Limited	$1.8B	30	Sell
COHANCE.NS	Cohance Lifesciences Limited	$1.8B	37	Hold
SIGACHI.NS	Sigachi Industries Limited	$140M	39	Hold
SUDEEPPHRM.NS	Sudeep Pharma Limited	$1.6B	41	Hold
INDOCO.NS	Indoco Remedies Limited	$237M	57	Hold

Peer medians: ROE 11.9% · P/E 42.5x · Gross margin 59.4%

Novartis India Limited (NOVARTIND.NS): Stock Score Summary

Novartis India Limited (NOVARTIND.NS) has a MoatMap StockRank of 30/100 based on Quality (72/100), Value (19/100), and Momentum (30/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price	$22.99
Market Cap	$475M
P/E (TTM)	55.30
Price/Book	6.60
Return on Equity	11.4%
Return on Invested Capital	15.7%
Debt/Equity	0.00x
Gross Margin	44.1%
Operating Margin	33.2%
Revenue Growth	18.6%
Free Cash Flow	$5M

Novartis India Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Novartis India Limited’s (NOVARTIND.NS) StockRank?: MoatMap’s StockRank for Novartis India Limited (NOVARTIND.NS) is 30/100, with a Sell signal. It is a composite of Quality (72), Value (19), and Momentum (30) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Novartis India Limited have an economic moat?: Novartis India Limited (NOVARTIND.NS) has a Quality factor score of 72/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Novartis India Limited a buy, hold, or sell?: MoatMap’s current signal for Novartis India Limited (NOVARTIND.NS) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Novartis India Limited in?: Novartis India Limited (NOVARTIND.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).